biote Corp. terminates Mary Puncochar, Head of Strategic Sales & Business Analytics

biote Corp.

Mary Puncochar terminated other than for cause; severance includes ~$202,781 base salary (9 months).
Also receives prorated target bonus of $54,075 and reimbursement for medical/dental/vision for 9 months.
Separation agreement includes customary release of all claims against the Company.
No replacement announced; Puncochar had served as Head of Strategic Sales since March 2024, prior CCO.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mary Puncochar

Head of Strategic Sales & Business Analytics

BTMD · biote Corp.

Effective: 2024-07-02
Filed: July 3, 2024, 7:59 PM ET

On July 2, 2024, biote Corp. (the “Company”) announced that Mary Puncochar, who has served as the Company’s Head of Strategic Sales & Business Analytics since March 2024 and, prior to that, served as Chief Commercial Officer from May 2023 to March 2024, was terminated other than for cause from all employment and officer positions with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mary Puncochar was terminated as Head of Strategic Sales & Business Analytics at biote Corp..

Action: terminated
Role: Head of Strategic Sales & Business Analytics

Exact text from the filing

On July 2, 2024, biote Corp. (the “Company”) announced that Mary Puncochar, who has served as the Company’s Head of Strategic Sales & Business Analytics since March 2024 and, prior to that, served as Chief Commercial Officer from May 2023 to March 2024, was terminated other than for cause from all employment and officer positions with the Company.

View on SEC.gov

biote Corp. filing history →

Source: SEC EDGAR

accession 0001193125-24-175041

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.